ebook Munafa Stock Market Course + Intraday & FNO calls  

GSK NEWS why is Glaxosmithkline Plc price falling or rising

GSK NEWS reasons for why stock price of Glaxosmithkline Plc is falling or rising

GSK Glaxosmithkline Plc is falling or rising technical reasons

Technical analysis forecast for Glaxosmithkline Plc Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Glaxosmithkline Plc GSK at this time. Stock is falling and might fall more.

It appears as if Glaxosmithkline Plc GSK gave a large move recently.

Stock of Glaxosmithkline Plc (GSK) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

My analysis of Glaxosmithkline Plc is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Glaxosmithkline Plc stays below 48.4, but if it comes above 48.4, then a intra day buy could be more profitable.
If you take a sell trade below 48.4, then use 48.4 as stoploss and 47 as target. However if you take a buy trade in Glaxosmithkline Plc, then use 48.4 as stoploss and 49.51 as target.

GSK Glaxosmithkline Plc is falling or rising NEWS fundamental reasons

GSK CFO Points to Cancer Drugs to Bridge £3.4 Billion Sales Forecast Gap MarketBeat Week in Review – 06/08 - 06/12GSK (NYSE:GSK) Chief Financial Officer Julie Brown said oncology products could help close the gap between analysts’ sales expectations and the company’s target of more than £40 billion in an - NEWS as on 2026-11-18 nasdaq.com

GSK Targets £40 Billion in Sales as HIV Patent Cliff Looms MarketBeat Week in Review – 06/08 - 06/12GSK (NYSE:GSK) expects to grow through the loss of patent protection for key HIV medicines, relying on a pipeline of new treatments, an expanding oncology business and continued dealmaking, President of Busine - NEWS as on 2026-11-17 nasdaq.com

GSK Accelerates Late-Stage Studies as It Targets COPD and Long-Acting Respiratory Treatments MarketBeat Week in Review – 06/08 - 06/12GSK (NYSE:GSK) is advancing a portfolio of long-acting medicines and combination treatments for respiratory and inflammatory diseases, with a particular focus on chronic obstructive pulmonary disease, a senior - NEWS as on 2026-11-09 nasdaq.com

More announcements and NEWS

GSK Glaxosmithkline Plc current price & indicator signals

Moving Averages for Glaxosmithkline Plc

  • 5Day Average: 48.76
  • 12Day Average: 49.92
  • 20Day Average: 49.85
  • 50Day Average: 49.31
  • 100Day Average: 50.3
  • 150Day Average: 50.7
  • 200Day Average: 52.2

GSK Indicators & signals

Indicator MACD (12,26,9)

49.33, 49.54, 0.15
Indicator MACD is in negative zone

Indicator ADX (14)

17.14, 25.89, 36.61
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 61
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GSK Glaxosmithkline Plc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
20 Fri Nov 2026 47.76 47.70 to 48.74 -0.13% 0.95 times
19 Thu Nov 2026 47.82 47.68 to 48.44 -1.56% 1.16 times
18 Wed Nov 2026 48.58 48.54 to 49.49 -1.34% 0.76 times
17 Tue Nov 2026 49.24 49.15 to 49.78 -2.32% 1.02 times
16 Mon Nov 2026 50.41 50.38 to 51.43 -0.08% 1.02 times
13 Fri Nov 2026 50.45 50.13 to 50.80 -0.38% 0.96 times
12 Thu Nov 2026 50.64 50.45 to 51.07 0.08% 0.88 times
11 Wed Nov 2026 50.60 49.79 to 50.64 -1.23% 0.94 times
10 Tue Nov 2026 51.23 51.02 to 51.89 -0.6% 0.91 times
09 Mon Nov 2026 51.54 50.59 to 51.64 2.4% 1.24 times
06 Fri Nov 2026 50.33 48.94 to 50.74 -0.16% 1.1 times
05 Thu Nov 2026 50.41 50.26 to 51.43 -1.45% 1.06 times

Videos related to: GSK NEWS why is Glaxosmithkline Plc price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

GSK NEWS why is Glaxosmithkline Plc price falling or rising

 

Back to top